Pt Bundamedik Tbk · IDX:BMHS

Pt Bundamedik Tbk — 9M24 Earnings Presentation

19 slides from Pt Bundamedik Tbk's earnings presentation, November 2024

  1. Slide 1: PT Bundamedik Tbk Earnings Call – 9M24 Results

    PT Bundamedik Tbk Earnings Call – 9M24 Results Nov 2024

  2. Slide 2: Leading Provider in Specialized Healthcare Services since 1973

    Leading Provider in Specialized Healthcare Services since 1973

  3. Slide 3: Bundamedik Tbk (BMHS) Ecosystem

    Bundamedik Tbk (BMHS) Ecosystem Expanding Presence RSIA Az Zahra 10 HOSPITALS Women & Children Hospitals 12 IVF CLINICS PADANG PONTIANAK BATAM 25 LABORATORIES Bunda Hospitals PALEMBANG MAKASSAR CLINICS NETWORK 3k++ (KLINIK PINTAR) YOGYAKARTA 126 FERTILITY CLINICS NETWORK (KFI) Jakarta Depok BANDUNG

  4. Slide 4: 9M24 Key Highlights

    9M24 Key Highlights 1 2 Consol Revenue Consolidated Gross Margin +5% vs 9M23 55% Higher +1% vs 9M23 +12% # of Outpatients +26% # of IP Days +9% # of Surgeries +25% # of Lab Tests 3 4 EBITDA New Hospitals +21% +62% vs 9M23 Net Revenue vs 9M23 Net Profit +123% +1975% vs 9M23 EBITDA improvement vs 9M23

  5. Slide 5: 9M24 Results

    @punva fp Piagnes | morvieyi «= SSBGP Paiccunic ERE OBO Pax, Ts, SEYNCA

  6. Slide 6: Financial & Operational Performance

    Financial & Operational Performance HIGHLIGHTS OF CONSOLIDATED RESULT Key Notes 2Q24 3Q24 QoQ (%) 9M23 9M24 YoY (%) 1 OPERATIONALS ('000) 1 Core Business in 9M24 # Outpatient 148.3 153.7 4% 410.7 460.5 12% • Hospitals metrics: Overall positive growth in #Outpatients, #Surgery, and #IP Days # Inpatie

  7. Slide 7: Hospital Volume

    Hospital Volume # OUTPATIENTS # IP ADMISSION +4% -5% +12% +41% +12% +20% 565.6 158.4 148.3 153.7 42.5 12.3 11.7 485.7 11.1 460.5 34.4 35.1 390.5 410.7 31.2 21.3 2021 2022 2023 9M23 9M24 1Q24 2Q24 3Q24 2021 2022 2023 9M23 9M24 1Q24 2Q24 3Q24 # IP DAYS # SURGERIES -6% -8% +34% +5% +26% +9% 117.3 123.8

  8. Slide 8: Financial Performance

    Financial Performance Consolidated NET REVENUE EBITDA EBITDA Margin Net Core Revenue (Rp B) (Rp B,% Margin) Covid EBITDA Net Covid Revenue Core EBITDA 34% +9% 1.186 1.082 +5% 4% 986 394 24% 29% 941 22% 251 18% 171 18% 644 608 23 169 15% 96% 100% 12 175 100% 145 71% 140 100% 96% 229 224 156 145 175 1

  9. Slide 9: Balance Sheet

    Balance Sheet Remains healthy CASH VS DEBT NET DEBT-TO-EBITDA (Rp B) (x) Net 418 -135 -216 225 405 272 Debt 1,425 2.2x 1,152 1.9x 1,027 1.1x 830 855 0.7x 625 613 629 622 518 490 100 -0.4x -0.6x 2019 2020 2021 2022 2023 9M24 2019 2020 2021 2022 2023 9M24 AR Days WORKING CAPITAL DAYS Inventory Days 58

  10. Slide 10: IVF Cycles

    IVF Cycles # OF IVF CYCLES (‘000) Improved compared to pre-Covid era +2% 4,25 4,35 3,82 3,72 3,64 2,73 9M19 9M20 9M21 9M22 9M23 9M24

  11. Slide 11: Diagnos

    Diagnos Focusing on genomic testing # OF TESTS (‘000) Covid Non Covid +25% +25% 649 639 YoY Number of 575 509 Test Volume 1% 27% 33% 5% 99% 73% 95% 67% 9M21 9M22 9M23 9M24 Promising Genomic revenue YoY increased by 53% YoY, contributing REVENUE (in bn rupiah) Covid Revenue Genomic Revenue Others Tes

  12. Slide 12: Strengthening Our Core

    Strengthening Our Core =SSBGP OP eicciinic ERE

  13. Slide 13: Strengthening Our COEs

    Strengthening Our COEs GynROSE Clinic Robotic Surgery Bunda Neuro Center Eras NICU/PICU Laparoskopi Bunda Health Center RSM Oncology Bunda General Hospital Bunda Women & Children Hospital Jakarta Klinik Tumbuh Kembang Anak Bunda Endoscopy Center

  14. Slide 14: Update Hospitals Result Initiatives

    Update Hospitals Result Initiatives Revenue Per payor in Hospital: 1Q23 9M23 9M24 1H24 Hospitals improvement perspective: • Increased +2.5pps in BPJS payor as our new hospitals mainly serves BPJS BPJS 20,0% 22.5% • Bunda well-known for OBGYN and Pediatric OOP 41,7% 40.9% specialization, this year we

  15. Slide 15: Ensuring Standardized Quality Process

    Ensuring Standardized Quality Process

  16. Slide 16: 2024 Update & Initiatives

    2024 Update & Initiatives @punva fp Piagnes | morvieyi «= SSBGP Paiccunic ERE OBO Pax, Ts, SEYNCA

  17. Slide 17: 2024 Key Initiatives

    2024 Key Initiatives 1 2 3 Improving overall medical Optimize and standardize Central procurement for services, facilities, branding pricing guideline pharma and consumables and patient experience 4 5 Implement data integration Establish culture and throughout BMHS group employee engagement

  18. Slide 18: 2024 One Bunda

    2024 One Bunda 276.165 (Existing Non-BPJS Patients) As of 31 September 2024, 41% Of existing Bunda's patients (non BPJS) have registered and used OneBunda Most Frequently Used Features is Janji Temu that generate ~107K Transactions 115.315 OneBunda’s Unique Users

  19. Slide 19: PT Bundamedik Tbk contact details

    PT Bundamedik Tbk Jl. Teuku Cik Ditiro No. 28, Menteng, Jakarta 10350 – Indonesia (62-21) 3192-3344

PT Bundamedik — 9M24 Earnings Presentation on 6ix